DelistingApr 21, 2026, 06:46 AM
Aimei Health faces Nasdaq delisting risk for late 10-K filing
AI Summary
Aimei Health Technology Co., Ltd. announced it received a notice from Nasdaq on April 17, 2026, indicating non-compliance with listing rules due to its failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. The report was due on March 31, 2026. The company now has 60 calendar days to either file the Annual Report or submit a plan to regain compliance, with a potential extension up to 180 days from the original due date. Failure to resolve this deficiency could result in the delisting of the company's securities from Nasdaq.
Key Highlights
- Aimei Health received a Nasdaq notice on April 17, 2026, for late 2025 Form 10-K filing.
- The Annual Report on Form 10-K was due on March 31, 2026.
- Company is non-compliant with Nasdaq Listing Rule 5250(c)(1).
- Aimei Health has 60 calendar days to file the report or submit a compliance plan.
- Failure to regain compliance could lead to delisting from Nasdaq.